Is a prolactin level of 505 considered normal?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Abnormal Prolactin Level Assessment

A prolactin level of 505 ng/mL is significantly abnormal and indicates pathological hyperprolactinemia, most likely due to a prolactinoma. 1

Reference Ranges and Interpretation

According to the Endocrine Society and American College of Endocrinology, normal prolactin reference ranges are:

  • Non-pregnant females: 3.0-30.0 ng/mL
  • Pregnant females: 10.0-209.0 ng/mL
  • Postmenopausal females: 2.0-20.0 ng/mL 1

A value of 505 ng/mL is well above these ranges and requires immediate evaluation.

Diagnostic Considerations

When prolactin levels exceed 200 ng/mL, the most likely cause is a prolactin-secreting pituitary adenoma (prolactinoma) 2. However, before concluding this diagnosis, consider:

  1. Rule out common confounders:

    • Pregnancy
    • Medication effects (antipsychotics, metoclopramide, etc.)
    • Primary hypothyroidism
    • Renal failure 3
  2. Consider macroprolactinemia:

    • Can cause elevated prolactin levels even >250 ng/mL
    • Present in up to 40% of non-physiological hyperprolactinemia cases 3
  3. Evaluate for "hook effect":

    • False low prolactin readings in large adenomas
    • Not applicable in this case as the level is already elevated 3

Next Steps in Management

For a patient with prolactin of 505 ng/mL:

  1. Imaging:

    • MRI of the pituitary is indicated to identify the likely macroprolactinoma 1
  2. Treatment initiation:

    • Dopamine agonist therapy is first-line treatment
    • Cabergoline is preferred due to better efficacy and tolerability
    • Initial dose: 0.25 mg twice weekly
    • Titrate by 0.25 mg twice weekly at 4-week intervals
    • Maximum dose typically up to 1 mg twice weekly 1, 2
  3. Monitoring:

    • MRI after 3 months to verify tumor size reduction
    • Then after 1 year, yearly for 5 years, and once every 5 years if stable 4
    • Cardiac monitoring with echocardiography:
      • Baseline before starting treatment
      • Yearly if dose >2 mg/week
      • Every 5 years if dose ≤2 mg/week 1

Common Pitfalls

  • Misdiagnosis: Not all pituitary masses with elevated prolactin are prolactinomas. Non-functioning pituitary adenomas can cause mild hyperprolactinemia (usually <100 ng/mL) through stalk compression 3

  • Inadequate follow-up: After initiating treatment, regular monitoring of both prolactin levels and tumor size is essential 1

  • Abrupt discontinuation: Can lead to rapid recurrence of hyperprolactinemia; proper tapering is required when discontinuing treatment 1

  • Resistance to treatment: Defined as failure to normalize prolactin or achieve significant tumor shrinkage after 3-6 months of maximally tolerated doses 1

A prolactin level of 505 ng/mL requires prompt evaluation and treatment, as it indicates significant pathology that can affect multiple body systems if left untreated.

References

Guideline

Management of Hyperprolactinemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hyperprolactinemia: pathophysiology and management.

Treatments in endocrinology, 2003

Research

Drug treatment of hyperprolactinemia.

Annales d'endocrinologie, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.